Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme-Reference-Cited by-同舟云学术

Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme

Published:2021-03-01 Issue:4 Volume:18 Page:1558-1572
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Checa-Chavarria Elisa¹,Rivero-Buceta Eva²,Sanchez Martos Miguel Angel¹,Martinez Navarrete Gema¹,Soto-Sánchez Cristina¹,Botella Pablo²^ORCID,Fernández Eduardo¹

Affiliation:

1. Institute of Bioengineering, Universidad Miguel Hernández, Elche, Spain and Centre for Network Biomedical Research (CIBER-BBN), Avenida de la Universidad s/n, 03202 Elche, Spain

2. Instituto de Tecnología Química, Universitat Politècnica de València-Consejo Superior de Investigaciones Científicas, Avenida de los Naranjos s/n, 46022 Valencia, Spain

Funder

Generalitat Valenciana

Consejo Superior de Investigaciones Científicas

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00968

Reference65 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. Glioblastoma and Other Malignant Gliomas